Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Survivorship: fatigue, version 1.2014. Journal of the National Comprehensive Cancer Network Denlinger, C. S., Ligibel, J. A., Are, M., Baker, K. S., Demark-Wahnefried, W., Friedman, D. L., Goldman, M., Jones, L., King, A., Ku, G. H., Kvale, E., Langbaum, T. S., Leonardi-Warren, K., McCabe, M. S., Melisko, M., Montoya, J. G., Mooney, K., Morgan, M. A., Moslehi, J. J., O'Connor, T., Overholser, L., Paskett, E. D., Raza, M., Syrjala, K. L., Urba, S. G., Wakabayashi, M. T., Zee, P., McMillian, N., Freedman-Cass, D. 2014; 12 (6): 876-887

Abstract

Many cancer survivors report that fatigue is a disruptive symptom even after treatment ends. Persistent cancer-related fatigue affects quality of life, because individuals become too tired to fully participate in the roles and activities that make life meaningful. Identification and management of fatigue remains an unmet need for many cancer survivors. This section of the NCCN Guidelines for Survivorship provides screening, evaluation, and management recommendations for fatigue in survivors. Management includes education and counseling, physical activity, psychosocial interventions, and pharmacologic treatments.

View details for PubMedID 24925198